This webpage contains legacy information. The product is either no longer available from the supplier or has been delisted at Labome.
product summary
company name :
R&D Systems
product type :
ELISA/assay
product name :
Human CD163 Quantikine ELISA Kit
catalog :
DC1630
quantity :
1 Kit
price :
655 USD
citations: 44
Reference
Sturgeon J, Mutasa K, Bwakura Dangarembizi M, Amadi B, Ngosa D, Dzikiti A, et al. Therapeutic interventions targeting enteropathy in severe acute malnutrition modulate systemic and vascular inflammation and epithelial regeneration. EBioMedicine. 2025;111:105478 pubmed publisher
Wang P, Yang L, Dong J, Liu W, Xie F, Lu Y, et al. The sEVs miR-487a/Notch2/GATA3 axis promotes osteosarcoma lung metastasis by inducing macrophage polarization toward the M2-subtype. Cancer Cell Int. 2024;24:301 pubmed publisher
Guan X, Hu R, Choi Y, Srivats S, Nabet B, Silva J, et al. Anti-TIGIT antibody improves PD-L1 blockade through myeloid and Treg cells. Nature. 2024;627:646-655 pubmed publisher
Rocafort M, Gootenberg D, Lu xe9 vano J, Paer J, Hayward M, Bramante J, et al. HIV-associated gut microbial alterations are dependent on host and geographic context. Nat Commun. 2024;15:1055 pubmed publisher
Lischka J, Schanzer A, de Gier C, Greber Platzer S, Zeyda M. Macrophage-associated markers of metaflammation are linked to metabolic dysfunction in pediatric obesity. Cytokine. 2023;171:156372 pubmed publisher
Chow F, Mundada N, Abohashem S, La Joie R, Iaccarino L, Arechiga V, et al. Psychological stress is associated with arterial inflammation in people living with treated HIV infection. Brain Behav Immun. 2023;113:21-28 pubmed publisher
Kawanaka M, Nishino K, Kawada M, Ishii K, Tanikawa T, Katsumata R, et al. Soluble CD163 is a predictor of fibrosis and hepatocellular carcinoma development in nonalcoholic steatohepatitis. BMC Gastroenterol. 2023;23:143 pubmed publisher
Zhu Y, Webster M, Walker A, MASSA P, Middleton F, Weickert C. Increased prefrontal cortical cells positive for macrophage/microglial marker CD163 along blood vessels characterizes a neuropathology of neuroinflammatory schizophrenia. Brain Behav Immun. 2023;111:46-60 pubmed publisher
Kincer L, Joseph S, Gilleece M, Hauser B, Sizemore S, Zhou S, et al. Rebound HIV-1 in cerebrospinal fluid after antiviral therapy interruption is mainly clonally amplified R5 T cell-tropic virus. Nat Microbiol. 2023;8:260-271 pubmed publisher
Ali R, Quinn G, Umarova R, Haddad J, Zhang G, Townsend E, et al. Longitudinal multi-omics analyses of the gut-liver axis reveals metabolic dysregulation in hepatitis C infection and cirrhosis. Nat Microbiol. 2023;8:12-27 pubmed publisher
Lee S, van den Berg N, Castley A, Divitini M, Knuiman M, Price P, et al. Long-Term Associations between Human Cytomegalovirus Antibody Levels with All-Cause Mortality and Cardiovascular Outcomes in an Australian Community-Based Cohort. Viruses. 2022;14: pubmed publisher
Parantainen J, Barreto G, Koivuniemi R, Kautiainen H, Nordstr xf6 m D, Moilanen E, et al. The biological activity of serum bacterial lipopolysaccharides associates with disease activity and likelihood of achieving remission in patients with rheumatoid arthritis. Arthritis Res Ther. 2022;24:256 pubmed publisher
Zuccal xe0 P, Latronico T, Marocco R, Savinelli S, Vita S, Mengoni F, et al. Longitudinal Assessment of Multiple Immunological and Inflammatory Parameters during Successful DAA Therapy in HCV Monoinfected and HIV/HCV Coinfected Subjects. Int J Mol Sci. 2022;23: pubmed publisher
Hara Y, Tsukiji J, Yabe A, Onishi Y, Hirose H, Yamamoto M, et al. Heme oxygenase-1 as an important predictor of the severity of COVID-19. PLoS ONE. 2022;17:e0273500 pubmed publisher
Vassallo M, Durant J, Fabre R, Lotte L, Sindt A, Puchois A, et al. Inflammatory Markers after Switching to a Dual Drug Regimen in HIV-Infected Subjects: A Two-Year Follow-Up. Viruses. 2022;14: pubmed publisher
Pedersen J, Rygg M, Chr xf8 is K, Sustarsic E, Gerhart Hines Z, Wever Albrechtsen N, et al. Influence of NAFLD and bariatric surgery on hepatic and adipose tissue mitochondrial biogenesis and respiration. Nat Commun. 2022;13:2931 pubmed publisher
Gilada T, Schnittman S, White E, Mercader J, Wang Y, Dasgupta S, et al. Immune Activation in Primary Human Immunodeficiency Virus: Influence of Duration of Infection, Treatment, and Substance Use. Open Forum Infect Dis. 2022;9:ofac155 pubmed publisher
Alexander L, McHorse G, Huebner J, Bay Jensen A, Karsdal M, Kraus V. A matrix metalloproteinase-generated neoepitope of CRP can identify knee and multi-joint inflammation in osteoarthritis. Arthritis Res Ther. 2021;23:226 pubmed publisher
Mueller M, Kern W, Usadel S, Pauly M, Cathomen T, Salzer U. Assessing the differential impact of chronic CMV and treated HIV infection on CD8+ T-cell differentiation in a matched cohort study: is CMV the key?. AIDS Res Ther. 2021;18:37 pubmed publisher
Cezar R, Winter A, Desigaud D, Pastore M, Kundura L, Dupuy A, et al. Identification of distinct immune activation profiles in adult humans. Sci Rep. 2020;10:20824 pubmed publisher
Magalh xe3 es J, Santos D, Correia I, Hetherington Rauth M, Ribeiro R, Raposo J, et al. Impact of combined training with different exercise intensities on inflammatory and lipid markers in type 2 diabetes: a secondary analysis from a 1-year randomized controlled trial. Cardiovasc Diabetol. 2020;19:169 pubmed publisher
Giron L, Colomb F, Papasavvas E, Azzoni L, Yin X, Fair M, et al. Interferon-α alters host glycosylation machinery during treated HIV infection. EBioMedicine. 2020;59:102945 pubmed publisher
Giron L, Tanes C, Schleimann M, Engen P, Mattei L, Anzurez A, et al. Sialylation and fucosylation modulate inflammasome-activating eIF2 Signaling and microbial translocation during HIV infection. Mucosal Immunol. 2020;13:753-766 pubmed publisher
Baker J, Wolfson J, Peterson T, Mooberry M, Gissel M, Mystakelis H, et al. Factor Xa Inhibition Reduces Coagulation Activity but Not Inflammation Among People With HIV: A Randomized Clinical Trial. Open Forum Infect Dis. 2020;7:ofaa026 pubmed publisher
Liu Q, Ou Q, Chen H, Gao Y, Liu Y, Xu Y, et al. Differential expression and predictive value of monocyte scavenger receptor CD163 in populations with different tuberculosis infection statuses. BMC Infect Dis. 2019;19:1006 pubmed publisher
Guo G, Zhu Y, Wu Z, Ji H, Lu X, Zhou Y, et al. Circulating monocytes accelerate acute liver failure by IL-6 secretion in monkey. J Cell Mol Med. 2018;22:4056-4067 pubmed publisher
Mascia C, Pozzetto I, Kertusha B, Marocco R, Del Borgo C, Tieghi T, et al. Persistent high plasma levels of sCD163 and sCD14 in adult patients with measles virus infection. PLoS ONE. 2018;13:e0198174 pubmed publisher
Fujimura T, Sato Y, Tanita K, Kambayashi Y, Otsuka A, Fujisawa Y, et al. Serum levels of soluble CD163 and CXCL5 may be predictive markers for immune-related adverse events in patients with advanced melanoma treated with nivolumab: a pilot study. Oncotarget. 2018;9:15542-15551 pubmed publisher
Keshtkar Jahromi M, Ouyang M, Keshtkarjahromi M, Almed S, Li H, Walston J, et al. Effect of influenza vaccine on tumor necrosis factor-like weak inducer of apoptosis (TWEAK) in older adults. Vaccine. 2018;36:2220-2225 pubmed publisher
de Armas L, Pallikkuth S, George V, Rinaldi S, Pahwa R, Arheart K, et al. Reevaluation of immune activation in the era of cART and an aging HIV-infected population. JCI Insight. 2017;2: pubmed publisher
Al Kindi S, Zidar D, McComsey G, Longenecker C. Association of Anisocytosis with Markers of Immune Activation and Exhaustion in Treated HIV. Pathog Immun. 2017;2:138-150 pubmed publisher
Mascia C, Vita S, Zuccalà P, Marocco R, Tieghi T, Savinelli S, et al. Changes in inflammatory biomarkers in HCV-infected patients undergoing direct acting antiviral-containing regimens with or without interferon. PLoS ONE. 2017;12:e0179400 pubmed publisher
Alvarado Vazquez P, Bernal L, Paige C, Grosick R, Moracho Vilrriales C, Ferreira D, et al. Macrophage-specific nanotechnology-driven CD163 overexpression in human macrophages results in an M2 phenotype under inflammatory conditions. Immunobiology. 2017;222:900-912 pubmed publisher
Kulkarni M, Bowman E, Gabriel J, Amburgy T, Mayne E, Zidar D, et al. Altered Monocyte and Endothelial Cell Adhesion Molecule Expression Is Linked to Vascular Inflammation in Human Immunodeficiency Virus Infection. Open Forum Infect Dis. 2016;3:ofw224 pubmed publisher
Meng Q, Sayin I, Canaday D, Mayanja Kizza H, Baseke J, Toossi Z. Immune Activation at Sites of HIV/TB Co-Infection Contributes to the Pathogenesis of HIV-1 Disease. PLoS ONE. 2016;11:e0166954 pubmed publisher
Ghislain M, Bastard J, Meyer L, Capeau J, Fellahi S, Gérard L, et al. Late Antiretroviral Therapy (ART) Initiation Is Associated with Long-Term Persistence of Systemic Inflammation and Metabolic Abnormalities. PLoS ONE. 2015;10:e0144317 pubmed publisher
Castley A, Berry C, French M, Fernandez S, Krueger R, Nolan D. Elevated plasma soluble CD14 and skewed CD16+ monocyte distribution persist despite normalisation of soluble CD163 and CXCL10 by effective HIV therapy: a changing paradigm for routine HIV laboratory monitoring?. PLoS ONE. 2014;9:e115226 pubmed publisher
Masia M, Robledano C, Ortiz de la Tabla V, Antequera P, Lumbreras B, Hernandez I, et al. Coinfection with human herpesvirus 8 is associated with persistent inflammation and immune activation in virologically suppressed HIV-infected patients. PLoS ONE. 2014;9:e105442 pubmed publisher
Beltrán L, Muñoz Hernández R, de Pablo Bernal R, García Morillo J, Egido J, Noval M, et al. Reduced sTWEAK and increased sCD163 levels in HIV-infected patients: modulation by antiretroviral treatment, HIV replication and HCV co-infection. PLoS ONE. 2014;9:e90541 pubmed publisher
Zizzo G, Guerrieri J, Dittman L, Merrill J, Cohen P. Circulating levels of soluble MER in lupus reflect M2c activation of monocytes/macrophages, autoantibody specificities and disease activity. Arthritis Res Ther. 2013;15:R212 pubmed
Førsvoll J, Kristoffersen E, Oymar K. Elevated levels of CXCL10 in the Periodic Fever, Aphthous stomatitis, Pharyngitis and cervical Adenitis syndrome (PFAPA) during and between febrile episodes; an indication of a persistent activation of the innate immune system. Pediatr Rheumatol Online J. 2013;11:38 pubmed publisher
Subramanian K, Du R, Tan N, Ho B, Ding J. CD163 and IgG codefend against cytotoxic hemoglobin via autocrine and paracrine mechanisms. J Immunol. 2013;190:5267-78 pubmed publisher
Shimizu M, Yachie A. Compensated inflammation in systemic juvenile idiopathic arthritis: role of alternatively activated macrophages. Cytokine. 2012;60:226-32 pubmed publisher
Moreno J, Dejouvencel T, Labreuche J, Smadja D, Dussiot M, Martin Ventura J, et al. Peripheral artery disease is associated with a high CD163/TWEAK plasma ratio. Arterioscler Thromb Vasc Biol. 2010;30:1253-62 pubmed publisher
product information
master code :
DC1630
SKU :
DC1630
product name :
Human CD163 Quantikine ELISA Kit
unit size :
1 Kit
description :
The Human CD163 Quantikine ELISA Kit from R&D Systems is a Solid Phase Sandwich ELISA that quantifies human CD163 in cell culture supernates (50 ul), serum (10 ul), heparin plasma (10 ul).
target :
CD163
category :
ELISAs
species :
Human
specificity :
Natural and recombinant human CD163
gene symbol :
CD163
kit type :
Solid Phase Sandwich ELISA
assay length :
4.5 hours
elisaSampleTypes :
Cell Culture Supernates (50 uL), Serum (10 uL), Heparin Plasma (10 uL)
elisaSensitivity :
0.613 ng/mL
elisaRange :
1.56 - 100 ng/mL
top caption :
Human CD163 ELISA Standard Curve
applications :
ELISA
USD :
655 USD
product details :
The Quantikine Human CD163 immunoassay is a 4.5 hour solid phase ELISA designed to measure human soluble CD163 in cell culture supernates, serum, and plasma. It contains NS0-expressed recombinant human CD163 and has been shown to accurately quantitate the recombinant factor. Results obtained using natural human CD163 showed linear curves that were parallel to the standard curves obtained using the Quantikine kit standards. These results indicate that this kit can be used to determine relative mass values for naturally occurring human CD163.
alt names :
CD_antigen: CD163, CD163, CD163 molecule, GHI/61, HbSR, Hemoglobin scavenger receptor, M130, macrophage-associated antigen, MM130, RM3/1, SCARI1, scavenger receptor cysteine-rich type 1 protein M130, sCD163, Soluble CD163
storage :
Store the unopened product at 2 - 8 ░C. Do not use past expiration date.
company information
R&D Systems
614 McKinley Place N.E.
Minneapolis, MN 55413
info@RnDSystems.com
https://www.rndsystems.com
800 343-7475
headquarters: USA
R&D Systems develops and manufactures high-quality proteins and serves as a world leader in immunoassays. R&D Systems also produces quality antibodies, antibody arrays, stem cell and cell culture products, and cell selection and detection products, serving the life science and diagnostics industry.